Showing 121 - 140 results of 2,115 for search '(( significant decrease cgas ) OR ( significant ((ns decrease) OR (nn decrease)) ))*', query time: 0.33s Refine Results
  1. 121
  2. 122
  3. 123

    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

    Published 2025
    “…Data represent mean values ± standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…”
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129

    HFD decreases ITM and alters metabolic homeostasis. by Tong Yue (6033305)

    Published 2025
    “…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”
  10. 130
  11. 131
  12. 132

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
  13. 133

    Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

    Published 2019
    “…Error bars represent ± SEM; n.s., non significant,*<i>P</i> < 0.05,**p < 0.01, ***p < 0.001, one-way ANOVA. …”
  14. 134
  15. 135

    Depletion of ERp29 decreases cellular Proinsulin. by Jeffrey Viviano (8871581)

    Published 2020
    “…(D, E) Transiently transfected Min-6 cells were lysed and analyzed by ELISA. Proinsulin levels decreased when transfected with ERp29-targeting siRNA as compared to controls (D, p = 0.0309), but Insulin content did not significantly change (E, p = ns).…”
  16. 136
  17. 137

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…Numbers of animals are shown. Asterisks or “ns” above each column indicate the significance when compared to PBS control (row 1, gray), ATRA (row 2, green), or clodronate (row 3, red) with ANOVA and <i>post-hoc</i> Tukey tests. …”
  18. 138
  19. 139

    GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage by Wieslaw M. Kazmierski (1706686)

    Published 2020
    “…The discovery of GSK2818713 (<b>13</b>), a nonstructural protein 5A (NS5A) HCV inhibitor characterized by a significantly improved genotype coverage relative to first-generation NS5A inhibitor daclatasvir (DCV), is detailed herein. …”
  20. 140

    Image_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…The present studies describe a novel use for ONP-302, employing an altered dosing scheme to reprogram myeloid cells resulting in significant enhancement of tumor immunity. ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”